Fifth Circuit appears supportive of FTC in Illumina appeal
A conservative-leaning federal appellate court appeared relatively open to the Federal Trade Commission’s order finding Illumina’s acquisition of Grail would likely harm competition for cancer-screening tests during oral arguments on Tuesday.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10